Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023

BUY
$41.39 - $81.0 $1.33 Million - $2.6 Million
32,109 Added 47.13%
100,244 $4.51 Million
Q3 2022

Oct 18, 2022

BUY
$72.36 - $113.1 $63,676 - $99,528
880 Added 1.31%
68,135 $4.93 Million
Q2 2022

Jul 19, 2022

BUY
$87.2 - $114.05 $5.86 Million - $7.67 Million
67,255 New
67,255 $7.22 Million
Q3 2021

Oct 13, 2021

SELL
$109.17 - $142.35 $513,099 - $669,045
-4,700 Closed
0 $0
Q2 2021

Jul 16, 2021

BUY
$100.34 - $115.69 $471,598 - $543,743
4,700 New
4,700 $508,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Portfolio

Follow Meag Munich Ergo, Kapitalanlagegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.